Primary human hepatocytes - A valuable tool for investigation of apoptosis and hepatitis B virus infection

Journal of Hepatology

Volumn 38, Issue 6, 2003, Pages 736-744

  Schulze Bergkamen, Henning ^a,b   Untergasser, Andreas ^a,c   Dax, Andreas ^a   Vogel, Heiko ^a   Büchler, Peter ^a   Klar, Ernst ^a   Lehnert, Thomas ^a   Friess, Helmut ^a   Büchler, Markus W ^a   Kirschfink, Michael ^a   Stremmel, Wolfgang ^a   Krammer, Peter H ^b   Müller, Martina ^a   Protzer, Ulrike ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Apoptosis; Culture; Hepatitis B virus; Hepatocytes; Human; Infection; Isolation; Liver; Primary

Indexed keywords

ADENOVIRUS VECTOR; COLLAGENASE; FAS ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; MALE; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0037564287     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00120-X     Document Type: Article

References (62)

1. Berry MN, Halls HJ, Grivell MB. Techniques for pharmacological and toxicological studies with isolated hepatocyte suspensions. Life Sci 1992;51:1-16.
2. Modriansky M, Ulrichova J, Bachleda P, Anzenbacher P, Anzenbacherova E, Walterova D, et al. Human hepatocyte - a model for toxicological studies. Functional and biochemical characterization. Gen Physiol Biophys 2000;19:223-35.
3. Gripon P, Diot C, Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 1993;192:534-40.
4. Galle PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 1994;106:664-73.
5. Fournier C, Sureau C, Coste J, Ducos J, Pageaux G, Larrey D, et al. In vitro infection of adult normal human hepatocytes in primary culture by hepatitis C virus. J Gen Virol 1998;79:2367-74.
6. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-6.
7. Ponchel F, Puisieux A, Tabone E, Michot JP, Froschl G, Morel AP, et al. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res 1994;54:2064-8.
8. Sprinzl MF, Oberwinkler H, Schaller H, Protzer U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol 2001;75:5108-18.
9. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 1969;43:506-20.
10. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
11. Reese JA, Byard JL. Isolation and culture of adult hepatocytes from liver biopsies. In Vitro 1981;17:935-40.
12. Guguen-Guillouzo C, Guillouzo A. Modulation of functional activities in cultured rat hepatocytes. Mol Cell Biochem 1983;54:35-56.
13. Hsu IC, Lipsky MM, Cole KE, Su CH, Trump BF. Isolation and culture of hepatocytes from human liver of immediate autopsy. In Vitro Cell Dev Biol 1985;21:154-60.
14. Berry MN, Grivell AR, Grivell MB, Phillips JW. Isolated hepatocytes - past, present and future. Cell Biol Toxicol 1997;13:223-33.
15. Bhatia SN, Toner M, Tompkins RG, Yarmush ML. Selective adhesion of hepatocytes on patterned surfaces. Ann N Y Acad Sci 1994;745:187-209.
16. Dich J, Vind C, Grunnet N. Long-term culture of hepatocytes: effect of hormones on enzyme activities and metabolic capacity. Hepatology 1988;8:39-45.
17. Chen HL, Wu HL, Fon CC, Chen PJ, Lai MY, Chen DS. Long-term culture of hepatocytes from human adults. J Biomed Sci 1998;5:435-40.
18. Ferrini JB, Rodrigues E, Dulic V, Pichard-Garcia L, Fabr JM, Blanc P, et al. Expression and DNA-binding activity of C/EBPalpha and C/EBPbeta in human liver and differentiated primary hepatocytes. J Hepatol 2001;35:170-7.
19. Galle PR, Krammer PH. CD95-induced apoptosis in human liver disease. Semin Liver Dis 1998;18:141-51.
20. Yoon J, Gores G. Death receptor-mediated apoptosis and the liver. J Hepatol 2002;37:400.
21. Peter ME, Krammer PH. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 1998;10:545-51.
22. Osawa Y, Banno Y, Nagaki M, Brenner DA, Naiki T, Nozawa Y, et al. TNF-alpha-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/Akt pathway in human hepatocytes. J Immunol 2001;167:173-80.
23. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-9.
24. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-30.
25. Rouquet N, Carlier K, Briand P, Wiels J, Joulin V. Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem Biophys Res Commun 1996;229:27-35.
26. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997;99:403-13.
27. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998;188:2033-45.
28. Müller M, Scaffidi CA, Galle PR, Stremmel W, Krammer PH. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis. Eur Cytokine Netw 1998;9:685-6.
29. Eichhorst ST, Müller M, Li-Weber M, Schulze-Bergkamen H, Angel P, Krammer PH. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol 2000;20:7826-37.
30. Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadler M, et al. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res 1991;51:2478-85.
31. Richter C, Gogvadze V, Schlapbach R, Schweizer M, Schlegel J. Nitric oxide kills hepatocytes by mobilizing mitochondrial calcium. Biochem Biophys Res Commun 1994;205:1143-50.
32. Feng G, Kaplowitz N. Mechanism of staurosporine-induced apoptosis in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002;282:G825-34.
33. Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, et al. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 1998;3:29-37.
34. Mochizuki K, Hayashi N, Hiramatsu N, Katayama K, Kawanishi Y, Kasahara A, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996;24:1-7.
35. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, et al. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994;152:3245-53.
36. Su F, Schneider RJ. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-9.
37. Pan J, Duan LX, Sun BS, Feitelson MA. Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-kappa B. J Gen Virol 2001;82:171-82.
38. Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, et al. X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway. J Biol Chem 2001;276:8328-40.
39. Rumin S, Gripon P, Le Seyec J, Corral-Debrinski M, Guguen-Guillouzo C. Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro. J Viral Hepat 1996;3:227-38.
40. Trauth BC, Klas C, Peters AM, Matzku S, Möller P, Falk W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-5.
41. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999;5:157-63.
42. Gripon P, Diot C, Theze N, Fourel I, Loreal O, Brechot C, et al. J Virol 1988;62:4136.
43. Irving MG, Roll FJ, Huang S, Bissell DM. Characterization and culture of sinusoidal endothelium from normal rat liver: lipoprotein uptake and collagen phenotype. Gastroenterology 1984;87:1233-47.
44. McCuskey RS, McCuskey PA, Urbaschek R, Urbaschek B. Species differences in Kupffer cells and endotoxin sensitivity. Infect Immun 1984;45:278-80.
45. Protzer U, Nassal M, Chiang PW, Kirschfink M, Schaller H. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc Natl Acad Sci USA 1999;96:10818-23.
46. Hussain RF, Nouri AM, Oliver RT. A new approach for measurement of cytotoxicity using colorimetric assay. J Immunol Methods 1993;160:89-96.
47. Scaffidi C, Medema JP, Krammer PH, Peter ME. J Biol Chem 1997;272:26953.
48. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
49. Kaufmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989;49:5870-8.
50. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-7.
51. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepatol 1999;6:357-65.
52. Müller M, Krammer PH. Mechanisms of apoptosis. In: Boyer J, Chisari F, Fausto N, Schachter D, Shafritz D, Arias I, editors. The liver: biology and pathobiology. 4th ed. Philadelphia: Lippincott, Williams and Wilkins, 2001. p. 187-205.
53. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994;19:1354-9.
54. Takahashi M, Matsue H, Matsushita M, Nakajima Y, Uchino J. Isolation and culture of human hepatocytes from resected liver tissue as a bioreactor for a hybrid artificial liver. Artif Organs 1993;17:653-9.
55. Schröder AJ, Blaheta RA, Scholz M, Encke A, Markus BH. [Isolation and separation of human adult hepatocytes from resected liver: cellular yield and purity using different methods]. Zentralbl Chir 1994;119:127-38.
56. Pichard-Garcia L, Hyland R, Baulieu J, Fabre JM, Milton A, Maurel P. Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo. Drug Metab Dispos 2000;28:51-7.
57. Alpini G, Lenzi R, Zhai WR, Liu MH, Slott PA, Paronetto F, et al. Isolation of a nonparenchymal liver cell fraction enriched in cells with biliary epithelial phenotypes. Gastroenterology 1989;97:1248-60.
58. Klöcker U, Schultz U, Schaller H, Protzer U. Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J Virol 2000;74:5525-33.
59. Jones RA, Johnson VL, Hinton RH, Poirier GG, Chow SC, Kass GE. Liver poly(ADP-ribose)polymerase is resistant to cleavage by caspases. Biochem Biophys Res Commun 1999;256:436-41.
60. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.
61. Fung CY, Fisher DE. p53: from molecular mechanisms to prognosis in cancer. J Clin Oncol 1995;13:808-11.
62. Hall SW, Strong JE, Broughton A, Frazier ML, Benjamin RS. Bleomycin clinical pharmacology by radioimmunoassay. Cancer Chemother Pharmacol 1982;9:22-5.